3.4. Therapeutic Efficacy of Triple Combination Correlates with Early Tumor Infiltration of CD8+ T Cells and Reduced Tumor Infiltration of Higly Suppresssive PD-1+ Treg Cells. The gene discussed is CD8A; the disease is neoplasm.